A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

NCT02491528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

563

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

BIOLOGICAL: insulin Aspart injection
BIOLOGICAL: insulin Aspart injection (NovoRapid)

Sponsor

Tonghua Dongbao Pharmaceutical Co.,Ltd